A detailed history of Algert Global LLC transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Algert Global LLC holds 48,270 shares of RMTI stock, worth $79,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,270
Previous 50,920 5.2%
Holding current value
$79,162
Previous $202,000 51.49%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$2.01 - $4.65 $5,326 - $12,322
-2,650 Reduced 5.2%
48,270 $98,000
Q3 2024

Nov 12, 2024

BUY
$1.67 - $4.4 $85,036 - $224,048
50,920 New
50,920 $202,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $17.5M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.